New antibiotic tested against superbugs in chinese hospitals

NCT ID NCT07268560

Recruiting now Disease control Sponsor: Sir Run Run Shaw Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

Some bacterial infections have become resistant to common antibiotics, making them very hard to treat. This study looks at a new drug combination, aztreonam-avibactam, in about 100 hospitalized adults in China with these resistant infections. Researchers will track how well patients respond to treatment and gather information to help doctors use this drug more effectively.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Aztreonam-Avibactam (antibiotic combination)
What this could lead to: If successful, this study could provide real-world evidence that aztreonam-avibactam is an effective treatment for drug-resistant infections, helping doctors choose the right therapy.
What could go wrong: This is an observational study, not a controlled trial, so results may be less definitive. The drug is new, and long-term safety or effectiveness in diverse patients is still unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COMPLICATED INTRA-ABDOMINAL INFECTIONS, CIAIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Healthcare-Associated Pneumonia nosocomial infection Pneumonia, Ventilator-Associated

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COMPLICATED INTRA-ABDOMINAL INFECTIONS, CIAIS HOSPITAL ACQUIRED PNEUMONIA (HAP) VENTILATOR-ASSOCIATED PNEUMONIA (VAP)

Contacts and locations

Locations

Sir Run Run Shaw Hospital
NOT_YET_RECRUITING

Hangzhou, Zhejiang, 310016, China
The First Affiliated Hospital of Nanchang University
RECRUITING

Nanchang, Jiangxi, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.